AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients

Angiogenesis represents a rate-limiting step during tumor progression. Targeting angiogenesis is already applied in cancer treatment, yet limits of anti-angiogenic therapies have emerged, notably because tumors adapt and recur after treatment. Therefore, there is a strong need to better understand t...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Langlois, Benoit, Saupe, Falk, Rupp, Tristan, Arnold, Christiane, van der Heyden, Michaël, Orend, Gertraud, Hussenet, Thomas
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279391/
https://ncbi.nlm.nih.gov/pubmed/25301723
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items